MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q3 2022. The put-call ratio across all filers is 1.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,945,406 | +20.2% | 72,159 | -19.9% | 0.10% | +63.5% |
| Q3 2022 | $1,618,000 | -22.7% | 90,089 | -3.4% | 0.06% | -58.3% |
| Q3 2021 | $2,093,000 | +152.8% | 93,274 | +211.1% | 0.15% | +7.1% |
| Q4 2020 | $828,000 | +107.5% | 29,981 | +5.6% | 0.14% | +76.2% |
| Q3 2020 | $399,000 | – | 28,400 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
| Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
| PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
| Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
| Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
| Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
| Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
| Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
| Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
| Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |